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CASE REPORT
A 60-year-old male pancreas and renal allograft recipient 
presented for evaluation of a painless, nonpruritic papular rash 
on his lower extremities. Seventeen months prior, he received 
a living unrelated donor kidney transplant for end-stage renal 
disease secondary to ANCA-associated antiglomerular base-
ment membrane disease, followed 7 months later by a pancreas 
allograft transplant for type 1 diabetes mellitus. He received 
alemtuzumab and thymoglobulin for induction therapy after 
renal and pancreas transplants, respectively, followed by pred-
nisone, mycophenolate mofetil and tacrolimus for maintenance 
immunosuppression. His posttransplant course was compli-
cated by acute pancreas allograft rejection requiring increased 
dose of prednisone, severe hypogammaglobulinemia requiring 
monthly intravenous immunoglobulin, and severe lymphopenia 
(CD4+ T helper cells of 0–5 cells/µL). He experienced multiple 
opportunistic infectious complications, initially with delayed 
onset primary cytomegalovirus pneumonitis and retinitis (with 
virologic recurrences), followed by influenza A  pneumonia 
with prolonged viral shedding, and recurrent dermatomal 
zoster. Subsequently, he developed overlapping infections due 
to Aspergillus sp. (invasive rhinosinusitis), Lichtheimia (Absidia) 
sp. (pneumonia), and Mycobacterium malmoense (bloodstream 
infection and pneumonia). At the time of his evaluation, he was 
receiving liposomal amphotericin B and posaconazole for in-
vasive aspergillus sinusitis and Lichtheimia pneumonia, and 
clarithromycin, rifabutin, and ethambutol for Mycobacterium 
malmoense infection. In addition, he was receiving prophylaxis 
with trimethoprim-sulfamethoxazole and valganciclovir.
A punch biopsy of the skin lesion in the lower extremity 
showed extensive vascular thrombosis and dermal necrosis. 
Clusters of small, 2 to 4 µm long, oval organisms (Figure 1) were 
observed in the dermis with a scant associated lymphohistiocytic 
inflammatory response. Organisms were located within cells and 
lumens of eccrine ducts and within smooth muscle and lumens 
of dermal arterioles. No budding was identified. A small number 
of organisms were positive with Grocott-Gomori’s methenamine 
silver (GMS) stain. Based on this appearance, a presumptive di-
agnosis of histoplasmosis was made, and he was continued on 
liposomal amphotericin B and posaconazole. Subsequent fungal 
cultures from skin biopsies were negative, and serologic and 
urine antigen testing for Histoplasma capsulatum were nega-
tive. H. capsulatum PCR (polymerase chain reaction) on lesional 
tissue also was negative. His rash remained unchanged on 
antifungal therapy and he subsequently developed ulcerations 
over the tip of his tongue with a yellowish eschar (Figure 1). 
Biopsy of the lesions showed similar organisms to those previ-
ously described.
During this time, he experienced profound pancytopenia. 
Bone marrow biopsy showed hypocellular bone marrow with 
no evidence of infection. Over concerns for aplastic anemia, 
he was given methylprednisolone intravenously followed by a 
course of prednisone therapy and subsequently cyclosporine, 
during which his rash worsened and he developed necrotic 
lesions on his fingertips (Figure 1). Biopsy of a finger lesion 
once again highlighted small organisms similar to those previ-
ously observed with focal GMS positivity. Organisms also were 
noted to be strongly Gram positive (Twort’s Gram stain), fo-
cally positive with the Ziehl-Neelsen stain, and focally birefrin-
gent with polarized light (Figure 1). Distinctive polar dot-like 
positivity was observed using Periodic acid–Schiff (PAS) stain 
without amylase. At this point, expert review by pathologists 
specializing in the pathology of infectious diseases at Mayo 
Clinic and the Centers for Disease Control and Prevention’s 
(CDC) Infectious Diseases Pathology Branch and Parasitic 
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Diseases Branch (Atlanta, GA) concluded that microsporidiosis 
was the likely diagnosis. Ryan blue modified trichrome stain on 
sputum and urine showed positively-staining structures (4 µm 
long) consistent with microsporidial spores. Electron micros-
copy and molecular studies at the CDC confirmed the diagnosis 
of microsporidiosis. Based on ultrastructure features (Figure 
1), including organism size, cell wall thickness, and number of 
polar tubule coils, the organism was identified as a Nosema-like 
organism. Molecular amplification and sequencing identified 
the organisms specifically as Anncaliia (formerly Brachiola, 
Nosema) algeriae. A  diagnosis of systemic disease was made 
based on the presence of microsporidia spores in the lower 
extremity, finger and tongue biopsies, as well as in urine and 
sputum samples.
The patient was started on albendazole, 400 mg twice daily, 
for disseminated microsporidiosis; unfortunately, his skin rash 
continued to progress, and his lesions on his fingers and oral 
cavity became necrotic with eschar formation. In addition to 
albendazole, itraconazole and clindamycin were added for 
potential enhanced activity [1]. Approval was received to use 
fumagillin from the US Food and Drug Administration under 
an investigational use protocol, but the drug unfortunately was 
not available from the manufacturer. At this point, the patient`s 
immunosuppressive medications were discontinued to enable 
his immune system to better mount a response to the infection. 
He continued to be debilitated. Because of his declining condi-
tion and nonresponse to antimicrobial therapy despite the dis-
continuation of all immunosuppressive regimens, he decided 
for comfort care. He expired 2 days after transition to comfort 
measures, 5 months after his clinical presentation.
The microsporidia are a large group of parasitic fungi 
encompassing several genera. They are obligate intracellular 
eukaryotic organisms that survive extracellularly by forming a 
spore with a thick cell wall. This spore contains a polar tubule, 
a coiled extrusion apparatus that the organism uses to inject its 
contents into a host cell. Once inside a host cell, intracellular 
replication leads to production of more spores that are released 
by cell rupture.
Microsporidia spores are readily identified in typical tissue, 
stool, or respiratory specimens. They are small (0.8–4  µm in 
greatest dimension) and are highlighted in direct specimen 
preparations using modifications to the trichrome stain that 
increase the chromotrope 2R component (eg, Ryan blue mod-
ified trichrome stain), allowing the stain to penetrate the thick 
cell wall [2]. The organisms also can be visualized on calcofluor 
white stain or using specific direct fluorescent antibody 
preparations. In formalin-fixed, paraffin-embedded tissues 
sections, spores are partially acid fast, stain variably with GMS, 
exhibit birefringence with polarized light, and have a polar dot-
like positivity using the PAS stain [3, 4] that corresponds to the 
polar tubule. Electron microscopy and, recently, nucleic acid 
amplification tests are used to identify the infecting genus and 
species [5].
Of the many different microsporidia capable of causing 
human disease, the 2 most common, Encephalitozoon 
intestinalis and Enterocytozoon bieneusi, are associated with 
diarrhea in immunosuppressed patients. These organisms 
also can cause disease in other body sites, including the lungs, 
kidneys, and central nervous system. Although their spores are 
small (<2 µm in greatest dimension), the spores of other genera 
such as Anncaliia are larger (≤4 µm) and may be confused with 
small yeasts. As such, initial misdiagnosis of microsporidia in-
fection as disseminated fungal infection has been reported in 
the literature [6]. This was observed in our patient as well, be-
cause he was initially misdiagnosed as having disseminated 
histoplasmosis due to the large size of the observed organisms 
and focal GMS positivity. However, 2 major aspects of this 
case were not supportive of this diagnosis: he was already re-
ceiving liposomal amphoterin B and posaconazole (both 
active against H.  capsulatum) and he had negative fungal 
A
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Figure 1. The patient developed several clinical manifestations of disseminated 
microsporidiosis due to Anncaliia algerae, including (A) ulcerative fingers and (B) 
oral lesions, as well as ulcerative intranasal lesions and a diffuse papular rash 
of the lower extremities (not shown). By light microscopic examination, spores 
were visible using (C) routine hematoxylin and eosin staining, (D) focally positive 
by Gomori methenamine silver stain, and (E) strongly Gram-positive by Gram stain. 
(F) The Periodic acid–Schiff stain showed polar dot-like positivity, which is char-
acteristic of microsporidial spores. Spores also were stained bright red using (G) 
the Ryan blue modified trichrome stain for microsporidia. (H) Electron microscopy 
showed features of a Nosema-like microsporidia, including large size, a thick cell 
wall, and a single row of polar filaments (arrow). Scale bars represent 20 µm, except 
in (H) in which the scale bar is 500 nm.
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culture, H. capsulatum urine antigen, serology, and PCR. These 
prompted additional expert review at Mayo Clinic and the CDC, 
which allowed for definitive identification of microsporidiosis. 
Electron microscopy and molecular amplification identified the 
organisms as A. algerae.
A.  algerae is an insect pathogen, infecting primarily 
mosquitos [7]. This organism only rarely has been reported to 
cause disease in humans. As of 2018, a review of published liter-
ature revealed a total of 7 cases isolated to Australia and North 
America. These include cases in patients following stem cell 
and solid organ transplantation. Disease typically manifests as 
skeletal muscle myositis, with over half of patients experiencing 
central nervous system or cardiac involvement [6]. Involvement 
of the vocal chords and bulbar muscles also has been described, 
leading to dysphagia and aspiration pneumonia [6, 8, 9]. 
The mechanism of transmission, including potential role of 
mosquitoes, is unknown.
An important feature common to our case and in previously 
reported cases is the severity of disease. This is likely attributed to 
the highly compromised immune status of the patients. Moreover, 
although albendazole typically is effective for other causes of 
microsporidiosis, a proportion of infections caused by A. algerae 
appear not to respond as efficiently to this drug [10, 11]. In the ab-
sence of controlled studies examining the efficacy of albendazole 
for this species in comparison to other microsporidia, it is difficult 
to attribute these instances of treatment failure to albendazole re-
sistance versus other factors, such as differences in host immu-
nity, disease burden, and organism virulence. Other less widely 
available drugs might enhance effect, such as fumagillin and 
nikkomycin Z [11]. Efforts to acquire fumagillin from the man-
ufacturer were unsuccessful. Discontinuation of the immuno-
suppressive drugs should be strongly considered in cases when 
antimicrobial therapy is very limited, particularly in recipients of 
kidney and pancreas allografts, in whom alternative treatments 
(dialysis and insulin, respectively) are available. This approach 
was not possible in this case as the diagnosis of microsporidiosis 
occurred later in the disease course.
Clinical familiarity with microsporidia is largely due to HIV-
associated cases prior to highly active antiretroviral therapy. 
These cases often were caused by a narrow spectrum of species 
and typically resulted in diarrhea with occasional extra-intestinal 
manifestations. In contrast, only very few cases are reported in non-
HIV immunocompromised hosts, such as transplant recipients. 
Our transplant patient was significantly immunocompromised, 
even when compared to the typical solid organ transplant recip-
ient—he was profoundly T-cell depleted, hypogammaglobulinemic, 
and pancytopenic. This severely immunosuppressed state is phe-
notypically manifested by sequential and concurrent infections 
with classic and unusual opportunistic pathogens, including, in 
this case, lesser known species of microsporidia [12].
In summary, we present a fatal case of disseminated 
microsporidiosis due to A. algerae in a highly immunocompro-
mised kidney and pancreas allograft recipient. Microsporidiosis 
was initially misdiagnosed as H.  capsulatum due to its 
overlapping morphologic features. Clinicians, pathologists, and 
microbiologists should consider microsporidiosis in their dif-
ferential diagnosis, particularly in profoundly immunocompro-
mised hosts, and seek expert consultation when appropriate.
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